Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Venous Thromboembolism 1Thrombosis 1Thrombophilia 1Thromboembolism 1Small Cell Lung Carcinoma 1Sarcoma 1Pulmonary Embolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Esophageal Neoplasms 1Digestive System Diseases 1

Interventions

Dalteparin 4Saline Solution 3Gemcitabine 3Enoxaparin 3Warfarin 2Tinzaparin 2Heparin, Low-Molecular-Weight 2Fondaparinux 2Aspirin 2130-nm albumin-bound paclitaxel 2palbociclib 1isoquercitrin 1enoxaparin sodium 1edoxaban 1apixaban 1alvocidib 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Rivaroxaban 1Pentetic Acid 1PEGPH20 1Nadroparin 1Minocycline 1Ketoconazole 1Heparin 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thromboembolism × enoxaparin sodium × Clear all
NCT01696760 2018-12-05

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

Ohio State University Comprehensive Cancer Center

Phase NA Completed
12 enrolled 6 charts
Sarcoma

Sarcoma, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡